EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.5.1.47 | Acute Lung Injury |
26781077 |
Hydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
4
1
0 |
| 2.5.1.47 | Acute Lung Injury |
30605726 |
GYY4137 attenuates LPS-induced acute lung injury via heme oxygenase-1 modulation. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
3
0 |
| 2.5.1.47 | Acute Lung Injury |
33577850 |
GYY4137 alleviates sepsis-induced acute lung injury in mice by inhibiting the PDGFR?/Akt/NF-?B/NLRP3 pathway. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
3
1
0 |
| 2.5.1.47 | Alveolar Bone Loss |
33529908 |
Hydrogen sulfide exacerbated periodontal inflammation and induced autophagy in experimental periodontitis. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
4
2
0 |
| 2.5.1.47 | Alzheimer Disease |
10568522 |
Gluthatione level is altered in lymphoblasts from patients with familial Alzheimer's disease. |
ongoing research
unassigned |
4
0 |
| 2.5.1.47 | Amebiasis |
26441896 |
Identification of natural inhibitors of Entamoeba histolytica cysteine synthase from microbial secondary metabolites. |
therapeutic application
unassigned |
1
0 |
| 2.5.1.47 | Arthritis |
31551776 |
TRPA1 Ion Channel Determines Beneficial and Detrimental Effects of GYY4137 in Murine Serum-Transfer Arthritis. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 2.5.1.47 | Arthritis, Rheumatoid |
31551776 |
TRPA1 Ion Channel Determines Beneficial and Detrimental Effects of GYY4137 in Murine Serum-Transfer Arthritis. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 2.5.1.47 | Atherosclerosis |
23713790 |
The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice. |
unassigned |
0 |
| 2.5.1.47 | Atherosclerosis |
26162843 |
Phosphinodithioate and Phosphoramidodithioate Hydrogen Sulfide Donors. |
causal interaction
therapeutic application
unassigned |
3
3
0 |
